Low-Dose Intrathecal Ziconotide for Spasticity From Primary Lateral Sclerosis: A Case Report.
Sign Up to like & getrecommendations! Published in 2019 at "A&A Practice"
DOI: 10.1213/xaa.0000000000000978
Abstract: Spasticity can be very debilitating and painful. We present a case of severe spasticity from primary lateral sclerosis refractory to intrathecal baclofen in doses up to 1100 μg/d. Baclofen was weaned down and switched to… read more here.
Keywords: intrathecal ziconotide; primary lateral; case; spasticity ... See more keywords